about
Genome-wide association study identifies five loci associated with lung functionScaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)Exacerbations of COPDMeasurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreathResearch in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future useFractional exhaled nitric oxide for the management of asthma in adults: a systematic reviewRecommendations for the management of cough in adults.Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthmaBronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthmaObjective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.Qualitative analysis of high-resolution CT scans in severe asthmaLung clearance index in adults with non-cystic fibrosis bronchiectasis.The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysisLong-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial.CRTH2 expression on T cells in asthma.Eosinophilic bronchitis: an important cause of prolonged cough.Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.Eosinophils in asthma and other allergic diseases.Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.Body mass and fat mass in refractory asthma: an observational 1 year follow-up studyExpression of CCR8 is increased in asthmaPrimary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy.IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma.The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.New insights into the relationship between airway inflammation and asthma.Prevalence, pathogenesis, and causes of chronic cough.Management of chronic cough.Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.Clinical applications of assessment of airway inflammation using induced sputum.The use of induced sputum in clinical trials.Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)New insights into the role of the mast cell in asthma.Management of asthma in adults: current therapy and future directions
P50
Q24629653-06BF641C-9EA5-4EF9-AD57-E3FD6A013A7BQ26740215-EA718FF4-392F-437E-AB68-315642D3B820Q26764891-9B967FBD-6B41-4B10-98C9-DDC2DE487138Q26781270-B27B23E2-E653-46A7-BF25-9BFD40803A1AQ26800021-87ADC62E-1EC2-443C-9B34-0A17309283E3Q27025354-B26D9817-285D-4DDD-8017-473BB610BFAFQ28074582-A227BB72-AB39-4796-BBDC-91572E1B85BDQ28260345-FD5BCD6C-82EE-47A3-B455-5D9366C353C2Q28390947-BFF9024A-966E-45FF-B9ED-A2161B3E6DA8Q30409292-58420A06-672D-4747-8252-CDA238D0D5CCQ30698745-03D7323C-408E-4BD3-9C86-EF284CA52E13Q30933471-2052BAF6-9655-46A2-9B2B-A89F8F649913Q33632072-88C0E42C-C668-4345-93DF-B12B56121223Q33674021-9DBC72CE-358F-46F6-8981-D26A079DC299Q33697776-37253DA0-A236-441F-9D61-F353049B8303Q33818701-435F1A98-F47A-45DE-A3B0-385CB1F2813AQ33982443-1AFD7F3F-EB19-46AB-9971-7C9E5D479B75Q34087412-F118D9DC-5695-444E-8BB8-45B1F4A4CC9BQ34154400-83A9C166-15AE-4C80-AA74-AE3D96A20A57Q34211965-FF0F1C96-A64D-473F-BE68-ACCC12B1DA19Q34255447-57CF4B69-A842-48E6-A1DB-148B1CD82803Q34289144-9ED1912D-12A5-4D54-810B-7DFE7D73F6ECQ34373069-D601A110-A8F8-4CE0-AFE4-2A1677777FFDQ34381417-C17CF276-6470-47F0-BED9-30FA0F4D3A87Q34411970-1C9AB937-0333-4F59-B58E-220F445245EDQ34514940-A71BBBEA-4E69-4973-BBB7-11587F7F3B2FQ34535033-0E458B66-658D-45D6-B53D-0E8BFF8100C9Q34542340-F09EF78C-3A0B-4348-9E50-D7F599AB2AD8Q34627601-B18E36A5-9905-45EC-8C09-DD623A8332F0Q34693644-877D5D8D-B6BC-4E10-BD5C-D1BE8762F072Q34767561-1F89E43C-6899-453A-BEF7-F2DF242AFB91Q34771772-F36C0094-A18A-4D71-A7E4-D7FC16B4F4C2Q34771784-C7C81881-9AEA-46B5-9E79-F1BF6DD7D7B2Q34808077-B7308D64-04F4-4755-A093-58B6178E8824Q34840443-A36D12AC-6832-45B8-AB81-DD110B4E93DEQ34933891-5BA3625E-48B5-4C92-A612-1795231E7AD6Q34933928-4448991F-00A3-46B5-AACA-F16554FF237DQ35096011-7320AAD8-92F8-4AAC-A9B6-1E6D97D166CBQ35129653-2D4DF291-8A0B-48C4-B77D-3FA6C9AB56CFQ35143482-29B2BF21-32A1-4923-9DA0-123E25D34258
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ian D. Pavord
@ast
Ian D. Pavord
@en
Ian D. Pavord
@es
Ian D. Pavord
@nl
Ian D. Pavord
@sl
type
label
Ian D. Pavord
@ast
Ian D. Pavord
@en
Ian D. Pavord
@es
Ian D. Pavord
@nl
Ian D. Pavord
@sl
altLabel
Ian Pavord
@en
Professor Ian Douglas Pavord
@en
prefLabel
Ian D. Pavord
@ast
Ian D. Pavord
@en
Ian D. Pavord
@es
Ian D. Pavord
@nl
Ian D. Pavord
@sl
P106
P1153
7006815656
P21
P31
P496
0000-0002-4288-5973